Health technology assessment agency gives recommendation for OPDIVO to treat non-small cell lung cancer
OPDIVO™ is the first immuno-oncology therapy for lung cancer in Canada to use the body's own immune system to fight cancer MONTREAL, June 8, 2016 /CNW/ - Canada's national health technology assessment body (CADTH)...
Read More